Invesco
INSY

Invesco’s Insys Therapeutics, Inc. INSY Stock Holding History

Invesco’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-38,695
Closed -$135K – 3915
2018
Q4 		$135K Buy
38,695
+4,892
+14% +$34K ﹤0.01% 3612
2018
Q3 		$341K Buy
33,803
+107
+0.3% +$854 ﹤0.01% 3571
2018
Q2 		$244K Buy
33,696
+10,307
+44% +$71.9K ﹤0.01% 3657
2018
Q1 		$141K Buy
23,389
+3,900
+20% +$32.2K ﹤0.01% 3644
2017
Q4 		$187K Sell
19,489
-684,473
-97% -$4.48M ﹤0.01% 3547
2017
Q3 		$6.25M Buy
703,962
+264,998
+60% +$2.73M ﹤0.01% 1840
2017
Q2 		$5.55M Sell
438,964
-79,734
-15% -$944K ﹤0.01% 1888
2017
Q1 		$5.45M Sell
518,698
-6,010
-1% -$64K ﹤0.01% 1926
2016
Q4 		$4.83M Buy
524,708
+66,969
+15% +$757K ﹤0.01% 2006
2016
Q3 		$5.4M Buy
457,739
+16,528
+4% +$251K ﹤0.01% 1917
2016
Q2 		$5.71M Buy
441,211
+53,321
+14% +$777K ﹤0.01% 1834
2016
Q1 		$6.2M Buy
387,890
+20,927
+6% +$397K ﹤0.01% 1699
2015
Q4 		$10.5M Sell
366,963
-914,408
-71% -$25.3M ﹤0.01% 1467
2015
Q3 		$36.5M Buy
1,281,371
+318,468
+33% +$11.7M 0.02% 883
2015
Q2 		$34.6M Buy
962,903
+358,959
+59% +$11.2M 0.01% 971
2015
Q1 		$17.6M Sell
603,944
-98,774
-14% -$2.61M 0.01% 1259
2014
Q4 		$14.8M Buy
702,718
+41,896
+6% +$828K 0.01% 1335
2014
Q3 		$12.8M Sell
660,822
-51,584
-7% -$810K 0.01% 1403
2014
Q2 		$11.1M Sell
712,406
-51,542
-7% -$833K ﹤0.01% 1500
2014
Q1 		$15.8M Buy
763,948
+139,231
+22% +$2.76M 0.01% 1303
2013
Q4 		$8.06M Sell
624,717
-116,817
-16% -$1.62M ﹤0.01% 1694
2013
Q3 		$8.65M Buy
+741,534
New +$6.09M ﹤0.01% 1556

Other funds holding INSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Invesco's INSY Position: Q1 2019 in Review

Invesco sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 38,695 shares — an estimated $135K sold.

Invesco first reported a position in INSY in Q3 2013 and held it in 22 quarters. The position peaked at $36.5M in Q3 2015. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • Invesco reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Invesco sold 38,695 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $135K.
  • Invesco first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 22 quarters.
  • Invesco's Insys Therapeutics, Inc. position peaked at $36.5M in Q3 2015.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.